Assignee
QUELL THERAPEUTICS LTD
GB·0 granted patents·11 pending applications·0 citations·filing 2021–2024
Top patents by PatentIndex Score
11 records- 0162US2024390422A1Anti-trem2 chimeric antigen receptorQUELL THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0259US2024052015A1Inducible signalling proteinQUELL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0352US2025283039A1Method for maintaining suppressive activity of regulatory t cellsQUELL THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0451US2025017967A1Anti-thymocyte globulin for immunomodulation of a subject with regulatory t cellsQUELL THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0549US2023138428A1Chimeric receptors for use in engineered cellsQUELL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0644US2025144137A1Nucleic acid constructs for expressing polypeptides in cellsQUELL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0743US2025250542A1Culture methodQUELL THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0841US2023235009A1Trem2 chimeric receptorQUELL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0939US2025170178A1Methods and products for culturing t cells and uses thereofQUELL THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1036US2023183311A1Polypeptide useful in adoptive cell therapyQUELL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1130US2024009237A1Method for cryopreserving engineered tregsQUELL THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when QUELL THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →